Industry Analysis: Regenerative Medicine, Biotech, Gene Therapies in North America: 1744144903
Executive Summary The regenerative medicine, biotech, and gene therapies sector in North America is experiencing a period of cautious optimism, driven by significant technological advancements and regulatory milestones despite market volatility. The global regenerative medicine market reached USD 17.19 billion in 2024, with a projected CAGR of 16.73% through 2033,